---
title: Using NF-kB â€˜fingerprints to identify therapeutic vulnerabilities within
  subsets of B cell malignancies
date: 2023-06-28T08:13:11.226Z
draft: false
featured: false
image:
  filename: featured
  focal_point: Smart
  preview_only: false
---
This exciting Blood Cancer UK funded project grant utilises the novel NF-kB fingerprinting technology developed by a collaboration between the Pepper and Mitchell team ([www.mitchell.science](http://www.mitchell.science/)) to predict the best drugs for patients with B cell malignancies.